Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
S.B. Drysdale, K. Cathie, F. Flamein, M. Knuf, A.M. Collins, H.C. Hill, F. Kaiser, R. Cohen, D. Pinquier, C.T. Felter, N.C. Vassilouthis, J. Jin, M. Bangert, K. Mari, R. Nteene, S. Wague, M. Roberts, P. Tissières, S. Royal, and S.N. Faust, for the MELODY Study Group. N Eng J Med. 2023; 389: 2425–2435.